-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MvdfD6AAhMvh+wP3PiGTNQY6MjdeQYW231xuBQaYjNYhx9YKwNFuEpixrjyWZ59+ MmMoMaTYFmouyP5PqVyKpQ== 0001140361-11-003429.txt : 20110120 0001140361-11-003429.hdr.sgml : 20110120 20110120091548 ACCESSION NUMBER: 0001140361-11-003429 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110118 FILED AS OF DATE: 20110120 DATE AS OF CHANGE: 20110120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thompson Jeffery S CENTRAL INDEX KEY: 0001510398 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 11537370 MAIL ADDRESS: STREET 1: 1140 HAVENBROOK COURT CITY: SUWANEE STATE: GA ZIP: 30024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANIKA THERAPEUTICS INC CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 6179326616 MAIL ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 3 1 doc1.xml FORM 3 X0203 3 2011-01-18 0 0000898437 ANIKA THERAPEUTICS INC ANIK 0001510398 Thompson Jeffery S 32 WIGGINS AVENUE BEDFORD MA 01730 1 0 0 0 See Footnote 0 D No securities (derivative or non-derivative) are beneficially owned. /s/ Kevin W. Quinlan 2011-01-20 EX-24 2 poa1.htm POWER OF ATTORNEY Unassociated Document
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS

Know all by these presents, that the undersigned hereby makes, constitutes and appoints each of Dr. Charles H. Sherwood and Kevin W. Quinlan, and each of them acting singly, as the undersigned’s true and lawful attorneys-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to:

(1)           prepare, execute, acknowledge, deliver and file any Form ID or Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Anika Therapeutics, Inc., a Massachusetts corporation (the “Company”), with the United States Securities and Exchange Commission, any securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the “Exchange Act”);

(2)           seek or obtain, as the undersigned’s representative and on the undersigned’s behalf, information on transactions in the Company’s securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and

(3)           perform any and all other acts which in the discretion of such attorney-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing.

The undersigned acknowledges that:

(1)           this Power of Attorney authorizes, but does not require, such attorneys-in-fact to act in their discretion on information provided to such attorney-in-fact without independent verification of such information;

(2)           any documents prepared and/or executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable;

(3)           neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned’s responsibility to comply with the requirements of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and

 
 
 
 
(4)           this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned’s obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act.

The undersigned hereby gives and grants the foregoing attorneys-in-fact, and any one of them acting singly, full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorney-in-fact of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney.

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to either of the attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 13th day of January, 2011.
 

 

 
 
/s/ Jeffery S. Thompson
  
 
Signature
  
     
     
 
    
 
Jeffery S. Thompson
  
 
Print Name
  
 
 -----END PRIVACY-ENHANCED MESSAGE-----